Results for pladecellekræft translation from Danish to English

pladecellekræft i hoved og hals.
squamous cell cancer of the head and neck.

risiko for progression til pladecellekræft
risk of progression to squamous cell carcinoma

en særlig type kræft i hoved og hals (pladecellekræft).
a certain type of cancer of the head and neck (squamous cell cancer).

visse former for hudkræft såsom basalcellekræft, pladecellekræft og keratoakantom
ome types of skin cancer such as basal cell carcinoma, cutaneous squamous cell carcinoma and keratoacanthoma

portrazza er et lægemiddel til behandling af fremskreden ikke-småcellet pladecellekræft i lungerne hos voksne.
portrazza is a medicine for treating advanced stages of a type of lung cancer known as squamous non- small cell lung cancer.

en hovedundersøgelse hos 1 093 patienter med fremskreden ikke-småcellet pladecellekræft i lungerne viste, at portrazza kan bevirke en beskeden forbedring i overlevelse, når det anvendes som tillæg til kemoterapi med gemcitabin og cisplatin.
a main study of 1,093 patients with advanced squamous non-small cell lung cancer showed that adding portrazza to gemcitabine and cisplatin chemotherapy can lead to a modest improvement in survival.

udvalget konkluderede derfor, at fordelene ved foscan opvejer risiciene til lindrende behandling af patienter med fremskreden pladecellekræft i hoved og hals, når anden medicin ikke virker, og når strålebehandling, operation eller systemisk kemoterapi ikke er hensigtsmæssig.
therefore, the committee decided that foscan’ s benefits are greater than its risks for the palliative treatment of patients with advanced head and neck squamous cell carcinoma who have failed other treatments and are not suitable for radiotherapy, surgery or systemic chemotherapy.

udvalget for humanmedicinske lægemidler (chmp) konkluderede, at fordelene ved docetaxel winthrop opvejer risiciene ved behandling af patienter med brystkræft, ikke- småcellet lungekræft, prostatakræft, kirtelkræft i maven og pladecellekræft i hoved - og halsregionen.
the committee for medicinal products for human use (chmp) decided that docetaxel winthrop’ s benefits are greater than its risks for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma and squamous cell head and neck cancer.